Jay Wilgar is the CEO of a Brantford company but he and his staff are sticklers when it comes to rules.
“Just so you know, we won’t be giving you any goodie baskets to take with you after the tour,” Wilgar says with a sly smile after greeting a visitor to Hemisphere Pharmaceuticals, a medical marijuana production facility that is looking to establish deep roots in the community.
“We’ve been working on this since 2013,” Wilgar, a Laurier University graduate.
“And there were some times when we’d be sitting in the board room here and it felt pretty lonely.”
Getting a new business up and running, especially in regulated new industry like medical marijuana, takes time, patience and a meticulous eye for detail. It began with the idea and one of the first few steps of the process was to find a facility.
Wilgar and company officials found what they were looking for in Brantford.
“We have 14,200-square-feet over two floors here,” Wilgar said. “It was empty space when we arrived and working with the people here has been nothing but positive.
“We’ve had people from the city, the police department and the fire department all come through the facility and they were great, very supportive.”‘
Since arriving in Brantford, the company has been putting in place its manufacturing process, as well as extra security measures. There are cameras everywhere. And entry to various rooms is restricted and monitored.
Anyone entering a room must wear a white lab coat, shoe coverings, a hairnet and, for those with facial hair, a mask.
Company officials have asked that its address not be published. But the facility is located in an industrial area.
Last December, Hemisphere received a licence from Health Canada to start producing medical marijuana at its Brantford facility. The company started growing medical marijuana in January.
There now are several rooms fitted with all the equipment needed to grow high quality marijuana.
Now, Wilgar has got plenty of company at work. Hemisphere has 15 employees with plans to add another five to 10 as the business grows.
Some of the jobs are part-time and have flexible hours to accommodate employees. The positions were filled with the help of the city’s economic development department.
The next step for the company is to get a Health Canada licence to sell its product. Company officials are optimistic but can’t say when that will happen.
The company’s products will be sold directly to a consumer who has received a prescription from a medical doctor.
Once a prescription or order is received, it will be vetted by staff at Hemisphere. The the order is filled and shipped in a plain, odourless package.
Meanwhile, the company is in the process of becoming a publicly traded company on the TSX Venture Exchange through a deal with Newstrike. Once that process is completed, Hemisphere will trade under the name Newstrike.
The move will give the company greater access to capital and further support its plans for the Brantford facility, the company said.
By Vincent Ball, Brantford Expositor

Source: www.brantfordexpositor.ca


 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less